Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 24, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on specific share transactions related to the SmithKline Beecham Employee Benefit Trust.
Material Changes and Transactions
- Purchase Transaction: On January 16, 2006, 7,180 Ordinary shares were purchased on behalf of participants in the GlaxoSmithKline Annual Investment Plan at a price of GBP 14.67 per share. This followed the reinvestment of a cash dividend paid on January 5, 2006.
- Sale Transaction: On January 19, 2006, 471 Ordinary shares were sold on behalf of a participant in the Annual Investment Plan at a price of GBP 14.33 per share.
- Transfer Transaction: On January 19, 2006, 655 Ordinary shares were transferred from the Trust to a participant in the Annual Investment Plan.
Management Commentary and Risks
The filing notes that the SmithKline Beecham Employee Benefit Trust is a discretionary fund for non-US employees and former employees. Director Mr. J. Heslop holds an interest in the shares held in the fund in the same capacity as other eligible employees. The transactions were notified in accordance with Disclosure Rule 3.1 4R (1) (b). No broader outlook, risks, or contingencies are discussed in this specific filing.
Investor Verification Points
- Verify the total number of shares held by the SmithKline Beecham Employee Benefit Trust to assess the scale of these transactions relative to the fund's size.
- Confirm the specific identity of the participant involved in the sale and transfer transactions to determine if any other connected persons were involved.
- Review the dividend reinvestment policy details to understand the mechanics of the January 16 purchase.